Hepatocellular Carcinoma and Hepatotoxicity
1,843 views · Published 3 July 2018 · 22:00 · Indexed 14 November 2026
Channel: Michigan Medicine · 2018 · Education
Natalyia Razumilava, MD, discusses the risks and testing for hepatocellular carcinoma (HCC), how many are meeting the Milan criteria at the time of diagnosis, the impact of a structured HCC surveillance program on outcomes and the newer GALADUS score for HCC diagnosis. She also addresses hepatotoxicity, herbal and dietary supplement induced liver injury and the leading causes of drug-induced liver injury (DILI) in children. Presented at the U-M 20th Annual Liver Disease Wrap Up CME. Learn more about liver disease and hepatology services at Michigan Medicine: https://www.uofmhealth.org/conditions-treatments/digestive-and-liver-health/liver-disease-and-hepatology
More from this channel
-
2:21
Breast cancer and osteoporosis: the link between them
-
4:21
Caregivers benefit from cancer support programs, U-M study f
-
4:54
Unique treatment brings hope to some with pancreatic cancer
-
1:46
Our Global Challenge
-
3:04
Teaching hand surgery techniques to Vietnamese surgeons
-
3:49
Calm the heart to stop a stroke?
-
2:32
UMHS honored by AHA for quality, safety
-
2:26
Students for Jamaica: Hagley Gap